Position in DHR
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,770,130
+$558,966 QoQ
Shares Held
9,293
+45.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#921
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS FINANCIAL LLC holds $26,797,423 across 11 Diagnostics & Research names. DHR ranks #3 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
33,339 | $16,714,841 | |
| 2 | LH |
Labcorp Holdings Inc.
|
14,623 | $4,094,440 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
9,293 | $1,770,130 | |
| 4 | NTRA |
Natera, Inc.
|
5,387 | $1,462,301 | |
| 5 | RVTY |
Revvity, Inc.
|
11,077 | $1,232,427 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
910 | $481,926 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,326 | $441,791 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
849 | $164,043 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,770,130 | 9,293 | Shares | Defined | 2026-07-17 | |
| 2026-03-31 | $1,211,164 | 6,388 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $1,790,840 | 7,823 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,342,814 | 6,773 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,185,239 | 6,000 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,239,225 | 6,045 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,754,220 | 7,642 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||